Zimmer Biomet exhibits data on less-invasive methods for degenerative disc disease, spondylolisthesis

Zimmer Biomet Spine Inc. announced positive data regarding its Aspen minimally invasive fusion system and Timberline systems from three studies to be presented at the Congress of Neurological Surgeons Annual Meeting.

According to a company press release, the data validated the systems as less invasive options for treatment of degenerative disc disease and spondylolisthesis.

“Zimmer Biomet’s clinical data demonstrates the benefits of less-invasive spinal fusion techniques, at a time when the industry is continuing to improve minimally invasive treatment options for patients,” Adam Johnson, group president of Zimmer Biomet Spine, Dental, Craniomaxillofacial and Thoracic, said in the release. “We look forward to discussing the 1-year outcomes of our randomized controlled trial, as well as executing more research in the future so we can continue to develop the evidence necessary to support excellent patient outcomes.”

Reference:

North American Spine Society Annual Meeting

Zimmer Biomet exhibits data on less-invasive methods for degenerative disc disease, spondylolisthesis